Temporal arteritis

Common Name(s)

Temporal arteritis, Giant cell arteritis

Giant cell arteritis, also known as temporal arteritis, occurs when one or more arteries become inflamed, swollen and tender. Arteries are the blood vessels that carry oxygen-rich blood from your heart to the rest of your body. Oxygenated blood leaves your heart through your body's main artery, the aorta. The aorta then divides into smaller arteries that deliver blood to all parts of your body, including your brain and internal organs. When these arteries become inflamed or swollen, blood flow decreases and less oxygen can travel to the respective parts of the body.

The exact cause is not known. Researchers believe giant cell arteritis may be an autoimmune disease. Autoimmune diseases occur when our body’s immune or defense system attacks its own healthy cells. Many people with giant cell arteritis often have polymyalgia rheumatica. Older individuals (people older than 50), women, and people of Northern European descent (especially Scandinavian) are more likely to have giant cell arteritis.

Giant cell arteritis can affect any artery, but most commonly affects the arteries that provide blood to the side of the face near the temple. The most common symptoms may include headache, jaw pain, blurred or double vision, fever, weight loss, and pain or stiffness in the neck, shoulder, or hips.

Your doctor can diagnose giant cell arteritis through a combination of a physical exam, blood tests, imaging, and tissue biopsy. Treatment may involve specific medications that help reduce inflammation within the affected arteries. Early diagnosis and treatment are important to avoid complications such as blindness or stroke. If you or a family member has been diagnosed with giant cell arteritis, talk with your doctor or specialist about the most current treatment options. Support groups are also a good resource and can help you connect with others affected by giant cell arteritis.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Temporal arteritis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Temporal arteritis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Temporal arteritis" returned 161 free, full-text research articles on human participants. First 3 results:

Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.
 

Author(s): Sebastian Unizony, Na Lu, Gunnar Tomasson, Yuqing Zhang, Peter A Merkel, John H Stone, J Antonio Aviña-Zubieta, Hyon K Choi

Journal: Arthritis Rheumatol. 2017 Jan;69(1):176-184.

 

Giant cell arteritis (GCA) and the use of glucocorticoids have both been associated with increased risk of venous thromboembolism (VTE). However, the possibility of confounding by indication has not been investigated. We undertook this study to examine the temporal risk of VTE in ...

Last Updated: 31 Dec 1969

Go To URL
PET/CT in giant cell arteritis: High 18F-FDG uptake in the temporal, occipital and vertebral arteries.
 

Author(s): Z Rehak, J Vasina, J Ptacek, T Kazda, Z Fojtik, P Nemec

Journal: Rev Esp Med Nucl Imagen Mol. ;35(6):398-401.

 

18F-FDG PET/CT imaging is useful in patients with fever of unknown origin and can detect giant cell arteritis in extracranial large arteries. However, it is usually assumed that temporal arteries cannot be visualized with a PET/CT scanner due to their small diameter. Three patients ...

Last Updated: 31 Dec 1969

Go To URL
Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries.
 

Author(s): Don Gilden, Teresa White, Nelly Khmeleva, Bradley J Katz, Maria A Nagel

Journal: J. Neurol. Sci.. 2016 May;364():141-3.

 

Recent analysis of archived temporal arteries (TAs) acquired from 13 pathology laboratories in the US, Canada, Iceland, France, Germany and Israel from patients with pathologically-verified giant cell arteritis (GCA-positive) and TAs from patients with clinical features and laboratory ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Temporal arteritis" returned 5 free, full-text review articles on human participants. First 3 results:

[Temporal arteritis: treatment controversies].
 

Author(s): J Balsalobre Aznar, J Porta-Etessam

Journal: Neurologia. 2010 Sep;25(7):453-8.

 

Although giant cell or temporal arteritis represents 5-10% of ischaemic optic neuropathies and is the most common arteritis in people over 60 years old. Currently there is no established treatment with oral glucocorticoids available.

Last Updated: 31 Dec 1969

Go To URL
[Temporal arteritis and cerebrovascular complications].
 

Author(s): Hildegunn Øverlie, Emilia Kerty

Journal: Tidsskr. Nor. Laegeforen.. 2005 Nov;125(21):2936-8.

 

Giant cell (temporal) arteritis is a systemic vasculitis of large and medium sized arteries causing severe visual loss and cerebrovascular accidents. We have treated several patients who developed stroke because of giant-cell arteritis despite high-dose corticosteroid treatment.

Last Updated: 31 Dec 1969

Go To URL
[Stroke as the first manifestation of temporal arteritis: three case reports and a review of its pathogenesis and treatment].
 

Author(s): A Belenguer-Benavides, C Vilar-Cambies, D Geffner-Sclarsky

Journal: Rev Neurol. ;39(3):227-32.

 

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Aetiology of TemporaL Arteritis Study
 

Status: Not yet recruiting

Condition Summary: Temporal Arteritis

 

Last Updated: 21 Oct 2015

Go to URL
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
 

Status: Recruiting

Condition Summary: Temporal Arteritis

 

Last Updated: 24 Oct 2017

Go to URL

Last Updated: 9 Aug 2017

Go to URL